Kennedy Capital Management, Inc. Xeris Biopharma Holdings, Inc. Transaction History
Kennedy Capital Management, Inc.
- $4.15 Billion
- Q3 2025
A detailed history of Kennedy Capital Management, Inc. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 1,211,583 shares of XERS stock, worth $8.78 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
1,211,583
Previous 816,147
48.45%
Holding current value
$8.78 Million
Previous $3.81 Million
157.49%
% of portfolio
0.24%
Previous 0.1%
Shares
5 transactions
Others Institutions Holding XERS
# of Institutions
236Shares Held
94.1MCall Options Held
251KPut Options Held
61.8K-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$71.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.84MShares$42.3 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...